Patients receiving chemotherapy, along with IP6 + Inositol did not have cytopenia, drop in leukocyte and platelet counts. ❋ Ivan Bacic (2010)
Clinical features, which are shared by the inherited and the acquired forms, include nonremitting high fever, hepatosplenomegaly, cytopenia of at least two lineages, and/or elevations in pro-inflammatory cytokines and soluble CD25. ❋ Unknown (2010)
Researchers concluded that PNH patients with hemolysis are at an increased risk of mortality and life-threatening complications, and that hemolysis is a potential risk factor for mortality and life-threatening complications independent of the presence of cytopenia. ❋ Unknown (2010)
Rarely, myelosuppression, thrombo-cytopenia, and leukopenia have been reported in patients taking colchicine. ❋ Unknown (2010)
In PNH patients with cytopenia, rates of mortality 19% vs. ❋ Unknown (2010)
RA with ringed sideroblasts, 4 RA with excess blasts-1, 24 refractory cytopenia with multilineage dysplasia, 14 refractory cytopenia with multilineage dysplasia with ringed sideroblasts, 4 MDS-unclassified, 2 MDS/Myeloproliferative disorder-U, 4 MDS-del 5q, and 1 ❋ Unknown (2010)
Michael lisanti, a overnight prozac delivery in the synaptosomes of auranofin biology, peroxisomal oncology, and cytopenia and multiresistant messenger at jefferson medical college at thomas jefferson university in philadelphia, said in a basada news release. ❋ Unknown (2010)
Data Registry in South Korea, evaluated the presence of hemolysis and cytopenia at the time of diagnosis and subsequent patient outcomes. ❋ Unknown (2010)
Refractory cytopenia with multilineage dysplasia (RCMD)
Reintroduction of therapy with EXJADE may be considered once the cause of the cytopenia has been elucidated.
Menatetrenone, a vitamin K2 analog, ameliorates cytopenia in patients with refractory anemia of myelodysplastic syndrome ❋ Unknown (2009)
Menatetrenone (K2, MK-4) Shown to be Beneficial in Pre-Leukemia Menatetrenone, a vitamin K2 analog, ameliorates cytopenia in patients with refractory anemia of myelodysplastic syndrome ❋ Unknown (2009)
Na, is a novel, synthetic, low molecular weight compound with a demonstrated protection of DNA, bone marrow stem cells, gastrointestinal crypt cells, and amelioration of cytopenia from radiation. ❋ Unknown (2009)
